Sublicense Revenue. TGTX shall pay to CTI [ * ] percent ([ * ]%) of all Sublicense Revenue received by TGTX (“Sublicense Revenue Share Payments”). Sublicense Revenue Share Payments shall be paid, on a Calendar Quarter basis, within 80 days after the end of each Calendar Quarter during which the respective Sublicense Revenue is received.
Appears in 2 contracts
Samples: Collaboration Agreement (Tg Therapeutics, Inc.), Collaboration Agreement (Checkpoint Therapeutics, Inc.)
Sublicense Revenue. TGTX shall pay to CTI [ * ] percent ([ * ]*%) of all Sublicense Revenue received by TGTX (“Sublicense Revenue Share Payments”). Sublicense Revenue Share Payments shall be paid, on a Calendar Quarter basis, within 80 days after the end of each Calendar Quarter during which the respective Sublicense Revenue is received.
Appears in 2 contracts
Samples: Collaboration Agreement (Checkpoint Therapeutics, Inc.), Collaboration Agreement (Checkpoint Therapeutics, Inc.)
Sublicense Revenue. TGTX shall pay to CTI [ * ] percent ([ * ]*%) of all Sublicense Revenue received by TGTX (“Sublicense Revenue Share Payments”). Sublicense Revenue Share Payments shall be paid, on a Calendar Quarter basis, within 80 days after the end of each Calendar Quarter during which the respective Sublicense Revenue is received. _______________________ * Confidential material redacted and filed separately with the Commission.
Appears in 1 contract
